Dr. James McCaffrey presents a complete end-to-end demonstration of decision tree regression from scratch using the C# language. The goal of decision tree regression is to predict a single numeric ...
On Friday, a Reddit-style social network called Moltbook reportedly crossed 32,000 registered AI agent users, creating what ...
Within days of release, Clawdbot became a sensation, delivering both the promise of productivity and a security nightmare, while giving a glimpse of our agent-run future writes Satyen K. Bordoloi ...
Check out our earnings calendar for this week, as well as our previews and recaps of the more noteworthy reports.
When I first read “The Chronology of Water,” I felt seen. It was a gritty, partially Oregon-based coming of age tale. And not just coming-of-age once as a teenager to adult, but a constant evolution ...
If you were looking for me last Saturday evening, you’d have found me at the Irene and Alan Wurtzel Theater for the TIMARA faculty recital, titled “Signal: Noise.” The Wurtzel Theater’s vibe was ...
The funding discussions highlight ongoing investor demand for new and unproven research labs looking to find novel approaches to AI that push the technology forward. Recursive’s goal is to develop ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Recursion Pharmaceuticals (RXRX) shares recently closed at US$3.98, with the stock showing a negative return over the past month and past 3 months, which may prompt investors to reassess its current ...
Earlier in January, Recursion Pharmaceuticals updated investors at the JP Morgan Healthcare Conference on its AI-powered drug discovery platform, clinical programs, and collaborations with partners ...
AI tools promise to compress drug development timelines from decades to years, accelerating data analysis and testing for ...
Ricursive Intelligence, a startup building an AI system to design and automatically improve AI chips, has raised $300 million at a $4 billion valuation. The company said Monday the round was led by ...